NCT03821051Recruiting
China Structural Ventricular Arrhythmias Registry
China Structural Ventricular Arrhythmias Registry, a Multicenter，Observational and Prospective Study.
Source: ClinicalTrials.gov · Last updated 29 Jan 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 centers in China,with clinical data to be abstracted from medical records ,and blood samples to be collected for finding promising risk indicators.The follow-up should be made every 6 mouths.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 27 Jan 2019
- Start date
- 24 Oct 2017
- Primary completion date
- 24 Oct 2022
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT03821051
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 24 Oct 2017 to the primary completion date, 24 Oct 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| China National Center for Cardiovascular Diseases Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.